1-10 of 10
Authors: Smita Nair
Sort by
Journal Article
IMMU-37. PRE-TREATMENT INNATE INFLAMMATION ASSOCIATES WITH SURVIVAL AFTER POLIO VIROTHERAPY AND CAN BE MODULATED TO SENSITIZE GLIOMAS TO IN SITU VACCINATION Free
Lalita Mazgaeen and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii160–viii161, https://doi.org/10.1093/neuonc/noae165.0630
Published: 11 November 2024
Journal Article
IMMU-11. NLRP3+ TUMOR-ASSOCIATED MYELOID CELLS ARE ENRICHED IN ASTROCYTIC GLIOMAS AND REPRESENT A THERAPEUTIC VULNERABILITY Free
Vidya Chandramohan and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v143, https://doi.org/10.1093/neuonc/noad179.0543
Published: 10 November 2023
Journal Article
IMMU-43. CXCR3 SIGNALING ENGAGES GLIOMA INFILTRATING T CELLS AND IS REQUIRED FOR THE ANTITUMOR EFFICACY OF INNATE STIMULATING IMMUNOTHERAPY Free
Michael Brown and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii140–vii141, https://doi.org/10.1093/neuonc/noac209.540
Published: 14 November 2022
Journal Article
TMOD-14. CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY Free
Adam Swartz and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi218, https://doi.org/10.1093/neuonc/noab196.875
Published: 12 November 2021
Journal Article
BIOM-20. TUMOR-INTRINSIC AND PERIPHERAL FEATURES ASSOCIATE WITH SURVIVAL AFTER POLIO VIROTHERAPY IN RECURRENT GBM Free
Michael Brown and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi14–vi15, https://doi.org/10.1093/neuonc/noab196.051
Published: 12 November 2021
Journal Article
CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA Free
Kristen Batich and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi51, https://doi.org/10.1093/neuonc/noab196.202
Published: 12 November 2021
Journal Article
THER-05. GENETICALLY STABLE POLIOVIRUS VECTOR CARRYING H3.3K27M ANTIGEN FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA BY INTRAMUSCULAR INJECTION Open Access
Mubeen Mosaheb and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii472, https://doi.org/10.1093/neuonc/noaa222.855
Published: 04 December 2020
Journal Article
ATIM-27. TUMOR MUTATIONAL BURDEN PREDICTS RESPONSE TO ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) IN MALIGNANT GLIOMA PATIENTS: ASSESSMENT OF TRANSCRIPTIONAL AND IMMUNOLOGICAL CORRELATES Free
Matthias Gromeier and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi7, https://doi.org/10.1093/neuonc/noz175.026
Published: 11 November 2019
Journal Article
IMMU-31. DYSFUNCTIONAL STING PATHWAY SIGNALING COMPROMISES INNATE IMMUNITY IN GLIOBLASTOMA Free
Michelle Bowie and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Pages vi127–vi128, https://doi.org/10.1093/neuonc/noy148.534
Published: 05 November 2018
Journal Article
IT-06PERSONALIZED IMMUNOTHERAPY FOR THE TREATMENT OF GLIOBLASTOMA
Get access
Gabriel De Leon and others
Neuro-Oncology, Volume 16, Issue suppl_5, November 2014, Page v111, https://doi.org/10.1093/neuonc/nou258.5
Published: 01 November 2014
Advertisement
Advertisement